Human studies on the μ opiate receptor agonist fentanyl: Neuroendocrine and behavioral responses
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The neuroendocrine and behavioral responses to the potent mu opiate receptor agonist Fentanyl (FE) have been systematically investigated in healthy male volunteers. These volunteers received, according to a randomized block design, different doses of FE: 0.1 mg/70 kg (n = 11), 0.2 mg/70 kg (n = 11), 0.25 mg/70 kg (n = 8), and saline (n = 11). FE induced a pronounced dose-dependent increase of plasma prolactin concentrations, which was significant at the lowest dose. In contrast, growth hormone was significantly stimulated by the highest FE dose only. Moreover, FE induced a maximum reduction of plasma cortisol concentrations at the lowest dose (0.1 mg/70 kg). In parallel, marked euphoric responses were also observed at this lowest FE dose. These results suggest a mu specific influence on all neuroendocrine and behavioral parameters investigated. Different responses of these parameters to different doses of FE, however, suggest a differential modulation of these parameters by the mu receptor agonist FE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These actions have been confirmed in subsequent studies with various types of opioids (143-146).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [143]
Citations
Cites
The Pharmacological Basis for Therapeutics
JOHNS, M. E. (1981) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1981.00790410063020 · Cited by 1,993
The Pharmacological Basis of Therapeutics
GOODMAN, L. S., & GILMAN, A. (1976) · Optometry and Vision Science · doi:10.1097/00006324-197604000-00018 · Cited by 1,260
Advances in biochemical psychopharmacology
Aprison, M. H. (1970) · Neuropharmacology · doi:10.1016/0028-3908(70)90062-6 · Cited by 1,175
Frontiers in Neuroendocrinology, 1969.
(1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-1-153_3 · Cited by 1,119
Catecholamine theories of reward: A critical review
Wise, R. A. (1978) · Brain Research · doi:10.1016/0006-8993(78)90253-6 · Cited by 766
Enkephalin may mediate euphoria and drive-reduction reward
BELLUZZI, J. D., & STEIN, L. (1977) · Nature · doi:10.1038/266556a0 · Cited by 450
Hormonal and metabolic responses to an enkephalin analogue in normal man
Stubbs, W. A., Jones, A., Edwards, C. R. W., Delitala, G., Jeffcoate, W. J., Ratter, S. J., Besser, G. M., Bloom, S. R., & Alberti, K. G. M. M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92100-1 · Cited by 353
The endocrinology of the opiates and opioid peptides
Morley, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90172-4 · Cited by 283
Chang, K.-J., Hazum, E., & Cuatrecasas, P. (1980) · Trends in Neurosciences · doi:10.1016/0166-2236(80)90059-4 · Cited by 262
Multiple Neurotransmitter Receptors
Snyder, S. H., & Goodman, R. R. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb12483.x · Cited by 223
Research works printed but not linked: 1
- Duka, 1986, Changes in prolactin and growth hormone secretion induced by an agonist/antagonist opioid, nalbuphine, Br J Clin Pharmacol, 17, 611
Cited by
Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment
Comer, S. D., & Cahill, C. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.005 · Cited by 302
Altered sexual function and decreased testosterone in patients receiving intraspinal opioids
Pake, J. A., Penn, R. D., & Ryan, W. G. (1994) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)90166-x · Cited by 140
Prolactin triggers pro-inflammatory immune responses in peripheral immune cells.
Brand, J., Frohn, C., Cziupka, K., Brockmann, C., Kirchner, H., & Luhm, J. (2004) · PubMed · Cited by 117
Reece, P. A., Sedman, A. J., Rose, S., Wright, D. S., Dawkins, R., & Rajagopalan, R. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb01991.x · Cited by 77
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Metadata
- Authors
- Hoehe, M., Duka, T., & Doenicke, A.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Hoehe, M.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 1988-01
- Volume
- 13
- Issue
- 5
- Pages
- 397-408
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2005404500
- Semantic Scholar
- d61b96d8cd2a212f9a32d758905d0e09c598b445
- Cited by
- 38
- References
- 61
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- fentanyl, mu-opioid receptor agonists, prolactin, growth hormone, cortisol, dose-dependent effects, euphoria, neuroendocrine response, opioid pharmacology, healthy men
- MeSH terms
- Adult, Affect, Blood Glucose, Clinical Trials as Topic, Dose-Response Relationship, Drug, Fentanyl, Humans, Hydrocortisone, Male, Pituitary Gland, Anterior, Prolactin, Random Allocation, Receptors, Opioid, Growth Hormone, Receptors, Opioid, mu
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human studies on the μ opiate receptor agonist fentanyl: Neuroendocrine and behavioral responses. https://app.cochat.ai/papers/10.1016/0306-4530(88)90046-7
- The paper
- Hoehe, M., Duka, T., & Doenicke, A. (1988). Human studies on the μ opiate receptor agonist fentanyl: Neuroendocrine and behavioral responses. Psychoneuroendocrinology. https://doi.org/10.1016/0306-4530(88)90046-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.